Open AccessOptimal Testing Choice and Diagnostic Strategies for Latent Tuberculosis Infection Among US-Born People Living with Human Immunodeficiency Virus (HIV)
Author(s) -
April C Pettit,
Jason E. Stout,
Robert Belknap,
Constance A. Benson,
Marie Nancy Séraphin,
Michael Lauzardo,
David Horné,
Richard S. Garfein,
Fernanda Maruri,
Christine Ho,
Jennifer Flood,
Lisa Pascopella,
Julie Higashi,
Marisa Moore,
Richard S. Garfein,
Constance A. Benson,
Robert Belknap,
Randall Reves,
Jason E. Stout,
Amina Ahmed,
Timothy R. Sterling,
April C Pettit,
Jason E. Stout,
Henry M. Blumberg,
Michael Lauzardo,
Marie Nancy Séraphin,
Richard Brostrom,
Renuka Khurana,
Wendy Cronin,
Susan E. Dorman,
Michiko Narita,
David Horné,
Thaddeus L. Miller
Publication year - 2020
Publication title -
clinical infectious diseases/clinical infectious diseases (online. university of chicago. press)
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/ciaa1135
Subject(s) - latent tuberculosis , medicine , tuberculin , tuberculosis , cohort , human immunodeficiency virus (hiv) , interferon gamma release assay , latent class model , quantiferon , prospective cohort study , mycobacterium tuberculosis , immunology , pathology , statistics , mathematics
Increased risk of progression from latent tuberculosis infection (LTBI) to tuberculosis (TB) disease among people living with human immunodeficiency virus (HIV; PLWH) prioritizes them for LTBI testing and treatment. Studies comparing the performance of interferon gamma release assays (IGRAs) and the tuberculin skin test (TST) among PLWH are lacking.